Neurosyphilis

被引：54

作者：

Marra C.M. ^{[1
]}

机构：

[1] Univ. of Washington Sch. of Medicine, Harborview Medical Center, Department of Neurology, Seattle, WA 98104-2499

来源：

Current Neurology and Neuroscience Reports | 2004年 / 4卷 / 6期

关键词：

Syphilis; Venereal Disease Research Laboratory; Secondary Syphilis; Early Syphilis; Treponema Pallidum Particle Agglutination;

D O I：

10.1007/s11910-004-0065-x

中图分类号：

学科分类号：

摘要：

Treponema pallidum, the bacterium that causes syphilis, invades the central nervous system early in the course of disease but causes persistent infection in only a subset of infected persons. Individuals with persistent infection or asymptomatic meningitis are at risk for developing symptomatic neurosyphilis if they are not treated with a drug regimen that achieves sufficient drug levels in cerebrospinal fluid to kill the organism. In this article, recent studies that address the risk, diagnosis, and management of neurosyphilis are discussed within the context of a brief review. Particular attention is given to current controversies. In the developed world, these issues are particularly relevant to persons who are infected with HIV. Copyright © 2004 by Current Science Inc.

引用

页码：435 / 440

页数：5

共 44 条

[21]

Marra C.M., Maxwell C.L., Smith S.L., Et al., Cerebrospinal fluid abnormalities in patients with syphilis: Association with clinical and laboratory features, J. Infect. Dis., 189, pp. 369-376, (2004)

[22]

Sexually transmitted diseases treatment guidelines 2002, MMWR Morb. Mortal. Wkly. Rep., 51, pp. 18-30, (2002)

[23]

Tramont E.C., Persistence of Treponema pallidum following penicillin G therapy. Report of two cases, JAMA, 236, pp. 2206-2207, (1976)

[24]

Marra C.M., Maxwell C.L., Tantalo L., Et al., Normalization of cerebrospinal fluid abnormalities after neurosyphilis therapy: Does HIV status matter?, Clin. Infect. Dis., 38, pp. 1001-1006, (2004)

[25]

Hart G., Syphilis tests in diagnostic and therapeutic decision making, Ann. Intern. Med., 104, pp. 368-376, (1986)

[26]

Marshall D.W., Brey R.L., Cahill W.T., Et al., Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection, Arch. Neurol., 45, pp. 954-958, (1988)

[27]

Marra C.M., Tantalo L.C., Maxwell C.L., Et al., Alternative cerebrospinal fluid tests to diagnose neurosyphilis in HIV-infected individuals, Neurology, 63, pp. 85-88, (2004)

[28]

Razavi-Encha F., Fleury-Feith J., Gherardi R., Bernaudin J.F., Cytologic features of cerebrospinal fluid in Lyme disease, Acta Cytol., 31, pp. 439-440, (1987)

[29]

Sindern E., Malin J.P., Phenotypic analysis of cerebrospinal fluid cells over the course of Lyme meningoradiculitis, Acta Cytol., 39, pp. 73-75, (1995)

[30]

Cepok S., Zhou D., Vogel F., Et al., The immune response at onset and during recovery from Borrelia burgdorferi meningoradiculitis, Arch. Neurol., 60, pp. 849-855, (2003)

← 1 2 3 4 5 →